Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 14 years
- Director since
- 2023
14 years of board service in total across 4 boards, counting each seat separately. Longest: Madrigal Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Madrigal Pharmaceuticals Inc. June 20, 202593.6%
-
Kiniksa Pharmaceuticals International plc June 3, 202597.6%
-
Kodiak Sciences Inc June 2, 202577.6%
-
Protara Therapeutics Inc. June 7, 202498.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 1, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +403 | — | — |
| Jun 17, 2026 | Madrigal Pharmaceuticals Inc. | Grant or award | +454 | — | — |
| May 29, 2026 | Kiniksa Pharmaceuticals International plc | Option exercise | +2,799 | — | — |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −40 | $506.68 | $20,267 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −320 | $508.24 | $162,637 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −151 | $510.36 | $77,064 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −610 | $511.40 | $311,954 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −439 | $512.50 | $224,988 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −40 | $512.97 | $20,519 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −343 | $514.67 | $176,532 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −657 | $515.92 | $338,959 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −723 | $516.87 | $373,697 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −1,497 | $517.59 | $774,832 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −782 | $518.76 | $405,670 |
| May 22, 2026 | Madrigal Pharmaceuticals Inc. | Open-market sale | −80 | $519.98 | $41,598 |
Questions about Richard S. Levy
What boards is Richard S. Levy on?
Richard S. Levy sits on the boards of Kiniksa Pharmaceuticals International plc, Kodiak Sciences Inc, Madrigal Pharmaceuticals Inc. and Protara Therapeutics Inc.
How long has Richard S. Levy served on boards?
Our records show at least 14 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.